The Dyslipidemia Drugs Use in Taiwan
碩士 === 高雄醫學大學 === 藥學研究所碩士在職專班 === 93 === ABSTRACT Background: Coronary Artery Disease is among the leading cause of death in various industrialized nations of the world, such as the United States and many countries in Europe. During the past decades, there has been a decline in the agricultur...
Main Authors: | Mei-Ju Lin, 林美汝 |
---|---|
Other Authors: | Hui-Fen Chiu |
Format: | Others |
Language: | zh-TW |
Published: |
2005
|
Online Access: | http://ndltd.ncl.edu.tw/handle/51280504219546563905 |
Similar Items
-
New Drugs for Treating Dyslipidemia: Beyond Statins
by: Chang Ho Ahn, et al.
Published: (2015-04-01) -
The use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia
by: D.D. Ivanov, et al.
Published: (2015-04-01) -
The Diffusion of New Drugs - Examples with Diabetes, Hypertension and Dyslipidemia
by: Wan-Chen She, et al.
Published: (2011) -
Prevalence and clinical significance of potential drug-drug interactions in hypertensive patients in Taiwan
by: Mei-Shu Lin, et al.
Published: (2006) -
EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA
by: P. Ya. Dovgalevsky, et al.
Published: (2016-01-01)